Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) EPS (Basic): 2020-2025

Historic EPS (Basic) for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to -$0.27.

  • GeneDx Holdings' EPS (Basic) rose 12.90% to -$0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.11, marking a year-over-year increase of 103.54%. This contributed to the annual value of -$1.94 for FY2024, which is 73.17% up from last year.
  • As of Q3 2025, GeneDx Holdings' EPS (Basic) stood at -$0.27, which was down 171.05% from $0.38 recorded in Q2 2025.
  • GeneDx Holdings' 5-year EPS (Basic) high stood at $0.98 for Q4 2021, and its period low was -$348.82 during Q1 2021.
  • For the 3-year period, GeneDx Holdings' EPS (Basic) averaged around -$0.87, with its median value being -$0.78 (2024).
  • Per our database at Business Quant, GeneDx Holdings' EPS (Basic) plummeted by 3,833.33% in 2022 and then spiked by 134.55% in 2025.
  • Over the past 5 years, GeneDx Holdings' EPS (Basic) (Quarterly) stood at $0.98 in 2021, then tumbled by 3,056.12% to -$28.97 in 2022, then surged by 96.82% to -$0.92 in 2023, then spiked by 125.00% to $0.23 in 2024, then rose by 12.90% to -$0.27 in 2025.
  • Its last three reported values are -$0.27 in Q3 2025, $0.38 for Q2 2025, and -$0.23 during Q1 2025.